|
Real-time Estimate
Cboe Europe
07:40:37 17/09/2026 pm IST
|
5-day change | 1st Jan Change | ||
| 39.55 DKK | +0.51% |
|
-8.93% | +9.81% |
| 11/09 | Lundbeck's Asedebart Gets US FDA Orphan Drug Designation for Endogenous Cushing's Syndrome | MT |
| 11/09 | Lundbeck wins US orphan drug status for asedebart in Cushing's syndrome | FW |
| Market Cap | 4.09TCr 631.69Cr 547.43Cr 517.41Cr 469.73Cr 880.37Cr 61TCr 885.64Cr 6.18TCr 2.39TCr 31TCr 2.37TCr 2.32TCr 98TCr | P/E 2026 * |
9.2x | P/E 2027 * | 9.01x |
|---|---|---|---|---|---|
| Enterprise Value | 4.49TCr 693.47Cr 600.96Cr 568.01Cr 515.67Cr 966.47Cr 67TCr 972.25Cr 6.78TCr 2.62TCr 34TCr 2.61TCr 2.55TCr 1,07600Cr | EV / Sales 2026 * |
1.73x | EV / Sales 2027 * | 1.57x |
| Free-Float |
30.74% | Yield 2026 * |
3.71% | Yield 2027 * | 3.36% |
| Markets | Quality | ||
|---|---|---|---|
Nasdaq Copenhagen
| LUN | Delayed | |
CBOE
| LUNc | Real-time | |
|
London S.E.
| 0ABR | Delayed | |
|
OTC Markets
| HLUBF | Delayed | |
|
Tradegate
| LDBB | Real-time | |
|
Wiener Boerse
| LUNA | End-of-day quote | |
|
Deutsche Boerse AG
| LDBB | Delayed | |
|
CBOE
| 0ABR | Real-time | |
|
Börse Stuttgart
| LDBB | Delayed | |
|
Boerse Muenchen
| LDBB | Real-time |
Last Transcript: Lundbeck
| 1 day | +0.83% | ||
| 1 week | -8.93% | ||
| Current month | -4.90% | ||
| 1 month | +9.20% | ||
| 3 months | +10.88% | ||
| 6 months | +15.89% | ||
| Current year | +9.81% |
| 1 week | 38.75 |  | 45 |
| 1 month | 36.1 | | 45 |
| Current year | 31.4 | | 45 |
| 1 year | 31.4 | | 45 |
| 3 years | 23.3 | | 45 |
| 5 years | 21.94 | | 45 |
| 10 years | 21.94 | | 45 |
| Manager | Title | Age | Since |
|---|---|---|---|
Charl van Zyl
CEO | Chief Executive Officer | 59 | 01/10/2023 |
Jörg Hornstein
DFI | Director of Finance/CFO | 49 | 01/09/2022 |
| Chief Operating Officer | 52 | - |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 67 | 25/03/2015 | |
| Director/Board Member | 67 | 25/03/2015 | |
| Director/Board Member | 60 | 20/03/2018 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.51% | -8.93% | - | - | 631.69Cr | |
| -1.12% | +0.11% | +27.38% | +106.37% | 10TCr | |
| -1.88% | -2.57% | +54.67% | +160.82% | 5.41TCr | |
| -3.47% | -5.30% | -16.11% | +228.95% | 2.12TCr | |
| -0.31% | -1.94% | -10.57% | -9.42% | 799.24Cr | |
| +0.27% | -2.67% | -37.40% | -36.09% | 686.59Cr | |
| +1.91% | -3.80% | -2.75% | +15.12% | 631.69Cr | |
| 0.00% | -3.03% | -20.22% | -31.21% | 597.89Cr | |
| +0.64% | +0.30% | -3.21% | +19.18% | 500.63Cr | |
| +2.08% | +3.80% | +13.32% | +13.24% | 387.11Cr | |
| Average | -0.11% | -1.69% | +0.57% | +51.88% | 2.39TCr | |
| Weighted average by Cap. | -1.19% | -0.84% | +23.29% | +113.12% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.59TCr 399.84Cr 346.5Cr 327.5Cr 297.32Cr 557.25Cr 38TCr 560.58Cr 3.91TCr 1.51TCr 19TCr 1.5TCr 1.47TCr 62TCr | 2.6TCr 401.75Cr 348.16Cr 329.07Cr 298.74Cr 559.91Cr 39TCr 563.26Cr 3.93TCr 1.52TCr 20TCr 1.51TCr 1.48TCr 62TCr |
| Net income | 458.13Cr 71Cr 61Cr 58Cr 53Cr 99Cr 6.78TCr 99Cr 691.37Cr 267.15Cr 3.44TCr 265.61Cr 259.71Cr 11TCr | 465.68Cr 72Cr 62Cr 59Cr 53Cr 100.16Cr 6.89TCr 100.76Cr 702.76Cr 271.55Cr 3.5TCr 269.98Cr 263.98Cr 11TCr |
| Net Debt | 400.29Cr 62Cr 54Cr 51Cr 46Cr 86Cr 5.93TCr 87Cr 604.09Cr 233.42Cr 3.01TCr 232.07Cr 226.92Cr 9.58TCr | -18Cr -2.74Cr -2.38Cr -2.25Cr -2.04Cr -3.82Cr -263.11Cr -3.85Cr -27Cr -10Cr -133.45Cr -10Cr -10Cr -425.38Cr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 17/26/17 | DKK 39.70 | +0.89% | 78,739 |
| 16/26/16 | DKK 39.35 | -4.61% | 1,67,291 |
| 15/26/15 | DKK 41.25 | -6.04% | 2,33,871 |
| 14/26/14 | DKK 43.90 | +0.23% | 2,13,220 |
| 11/26/11 | DKK 43.80 | +0.34% | 1,67,589 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- HLUN B Stock
- LUN Stock
Select your edition
All financial news and data tailored to specific country editions
